Vaxcyte Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio3.094.823.974.423.91
Price/Tangible Book3.094.823.974.423.91
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-0.20%-0.37%-0.36%-0.32%-0.45%
Return on Assets (ROA)-0.14%-0.24%-0.22%-0.18%-0.24%
Return on Capital Employed (ROCE)-0.17%-0.37%-0.24%-0.35%-0.26%
Leverage & Solvency Ratios
Debt/Equity0.020.020.020.06
Liquidity Ratios
Current Ratio12.767.5423.268.938.30
Quick Ratio12.617.4623.088.618.25
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-0.05%-0.07%-0.06%-0.08%-0.07%
FCF Yield-0.06%-0.06%-0.05%-0.10%-0.04%
Buyback Yield-0.26%-0.50%-0.25%-0.76%-6.79%